Prevalence of markers of hepatitis B virus infection or vaccination in HBsAg-negative subjects

Blood Transfusion

Volumn 10, Issue 3, 2012, Pages 344-350

  De Paschale, Massimo ^a   Manco, Maria Teresa ^a   Belvisi, Luisa ^a   Brando, Bruno ^a   Latella, Stefania ^a   Agrappi, Carlo ^a   Mirri, Paola ^a   Gatti, Arianna ^a   Clerici, Pierangelo ^a  

^a Hospital of Legnano   (Italy)

Author keywords

Epidemiology; HBV markers; HBV vaccination

Indexed keywords

BIOLOGICAL MARKER; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ADULT; ANAMNESIS; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; FEMALE; HEPATITIS B; HUMAN; HUMAN TISSUE; ITALY; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; VACCINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; INFANT; ITALY; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; VACCINATION;

EID: 84865177817     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2012.0085-11     Document Type: Article

References (38)

1. Romanò L, Paladini S, Van Damme P, Zanetti AR. The worldwide impact of vaccination on the control and protection of viral hepatitis B. Dig Liv Dis 2011; 43 (Suppl. 1): S2-7.
2. Merrill RM, Hunter BD. Seroprevalence of markers for hepatitis B viral infection. Int J Infect Dis 2011; 15: e78-121.
3. Torbenson M, Thomas DL. Occult hepatitis B. Lancet Infect Dis 2002; 2: 479-86. (Pubitemid 34826853)
4. Almeida Neto C, Strauss E, Sabino EC, et al. Significance of isolated hepatitis B core antibody in blood donors from Sao Paulo. Rev Inst Med Trop Sao Paulo 2001; 43: 203-8. (Pubitemid 33611970)
5. Douglas DD, Taswell HF, Rakela J, Rabe D. Absence of hepatitis B virus DNA detected by polymerase chain reaction in blood donors who are hepatitis B surface antigen negative and antibody to hepatitis B core antigen positive from a United States population with a low prevalence of hepatitis B serologic markers. Transfusion 1993; 33: 212-6. (Pubitemid 23073643)
6. Kitchen AD, Harrison TJ, Meacock TJ, et al. Incidence and significance of hepatitis B core antibody in a healthy blood donor population. J Med Virol 1988; 25: 69-75.
7. Joller-Jemelka HI, Wicki AN, Grob PJ. Detection of HBs antigen in "anti-HBc alone" positive sera. J Hepatol 1994; 21: 269-72. (Pubitemid 24270557)
8. Hennig H, Puchta I, Luhm J, et al. Frequency and load of hepatitis B virus DNA in first-time blood donors with antibodies to hepatitis B core antigen. Blood 2002; 100: 2637-41.
9. Lok AS, Lai CL, Wu PC. Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implications in hepatitis B vaccination programs. Hepatology 1988; 8: 766-70.
10. Bernvil SS, Andrews V, Kuhns MC, McNamara AL. Hepatitis B core antigen antibody as an indicator of a low grade carrier state for hepatitis B virus in a Saudi Arabian blood donor population. Transfus Sci 1997; 18: 49-53.
11. World Health Organization. Hepatitis B Fact Sheet No. 204 (Revised October 2008). (http://who.int/mediacentre/factsheets/fs204/en).
12. Ng KP, Saw TL, Baki A, et al. Impact of the Expanded Program of Immunization against hepatitis B infection in school children in Malaysia. Med Microbiol Immunol 2005; 194: 163-8. (Pubitemid 41202533)
13. Ni YH, Huang LM, Chang MH, et al. Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategies. Gastroenterology 2007; 132: 1287-93.
14. Piazza M, Da Villa G, Picciotto L, et al. Mass vaccination against hepatitis B in infants in Italy. Lancet 1988; 2: 1132.
15. Zanetti AR, Tanzi E, Romanò L, Grappasonni I. Vaccination against hepatitis B: the Italian strategy. Vaccine 1993; 11: 521-4. (Pubitemid 23130856)
16. Stroffolini T, Guadagnino V, Chionne P, et al. A population based survey of hepatitis B virus infection in a southern Italian town. Ital J Gastroenterol Hepatol. 1997; 29: 415-8.
17. Romanò L, Paladini S, Tagliacarne C, et al. The changing face of the epidemiology of type A, B, and D viral hepatitis in Italy, following the implementation of vaccination. Vaccine 2009; 27: 3439-42.
18. Stroffolini T, Mele A, Tosti ME, et al. The impact of hepatitis B mass immunisation campaign on the incidence and risk factors of acute hepatitis B in Italy. J Hepatol 2000; 33: 980-5.
19. Mele A, Tosti ME, Mariano A, et al. Acute hepatitis B 14 years after implementation of universal vaccination in Italy: areas of improvement and emerging challenges. Clin Infect Dis 2008; 46: 868-75. (Pubitemid 351417188)
20. Sagnelli E, Stroffolini T, Mele A, et al Italian Hospitals' Collaborating Group. Chronic hepatitis B in Italy: new features of an old disease - approaching the universal prevalence of hepatitis B and antigen-negative cases and the eradication of hepatitis D infection. Clin Infect Dis 2008; 46: 110-3. (Pubitemid 351263570)
21. Giusti G, Gaeta GB, Russo M, Bedarida G. HBsAg carriers among blood donors in Italy-a multicentre study in 107 blood banks. Infection 1989; 17: 237-9. (Pubitemid 19207989)
22. Velati C, Fomiatti L, Baruffi L et al. Criteria for hepatitis B virus screening and validation of blood components in Italy: the position of the SIMTI HBV working group. Blood Transfus 2011; 9: 455-61.
23. Stroffolini T. The changing pattern of hepatitis B virus infection over the past three decades in Italy. Dig Liver Dis 2005; 37: 622-7. (Pubitemid 44356074)
24. Fabris P, Baldo V, Baldovin T, et al. Changing epidemiology of HCV and HBV infections in Northern Italy: a survey in the general population. J Clin Gastroenterol 2008; 42: 527-32. (Pubitemid 351572246)
25. Da Villa G, Romanò L, Sepe A, et al. Impact of hepatitis B vaccination in a highly endemic area of south Italy and long-term duration of anti-HBs antibody in two cohorts of vaccinated individuals. Vaccine 2007; 25: 3133-6.
26. D'Amelio R, Matricardi PM, Biselli R, et al. Changing epidemiology of hepatitis B in Italy: public health implications. Am J Epidemiol 1992; 135: 1012-8.
27. Salvaneschi L, Poma R, Pagani A. I problemi virali delle trasfusioni. In: Bombardieri E, Cavallo G, Landolfo S, editors. Argomenti di Laboratorio per la Virologia. Brescia: Edizioni CLAS International; 1990. p. 179.
28. Manzini P, Girotto M, Borsotti R, et al. Italian blood donors with anti-HBc and occult hepatitis B virus infection. Haematologica 2007; 92: 1664-70. (Pubitemid 350248246)
29. Caritas migrantes. Immigrazione Dossier Statistico 2008 XVIII rapporto. Roma: Edizioni Idos; 2008.
30. De Paschale, Biagiotti S, Chianese R, et al. Variazione nel tempo della prevalenza dei marcatori dell'epatite B in donatori di sangue. La Trasfusione del Sangue 2001; 46: 335-40.
31. Tafuri S, Prato R, Martinelli D, et al. Prevalence of hepatitis B, C, HIV and syphilis markers among refugees in Bari, Italy. BMC Infect Dis 2010; 10: 213.
32. Majori S, Balbo V, Tommasi I, et al. Hepatitis A, B, and C infection in a community of sub-Saharan immigrants living in Verona (Italy). J Travel Med 2008; 15: 323-7.
33. McMahon BJ, Parkinson AJ, Helminiak C, et al. Response to hepatitis vaccine of persons positive for antibody to hepatitis B core antigen. Gastroenterology 1992; 103: 590-4.
34. Parkinson AJ, McMahon BJ, Hall D, et al. Comparison of enzyme immunoassay with radioimmunoassay for the detection of antibody to hepatitis B core antigen as the only marker of hepatitis B infection in a population with a high prevalence of hepatitis B. J Med Virol 1990; 30: 253-7. (Pubitemid 20203827)
35. Zanetti AR, Romanò L, Zappa A, Velati C. Changing patterns of hepatitis B infection in Italy and NAT testing for improving the safety of blood supply. J Clin Virol 2006; 36 (Suppl. 1): S51-5. (Pubitemid 44016157)
36. Velati C, Romanò L, Fomiatti L, et al. For the Italian Group for the Study of Tranfusion-Transmissible Diseases. HBV DNA detection in HBsAg neg/anti-core positive Italian first time blood donors. Vox Sang 2006; 91 (Suppl. 3): 66
37. Velati C, Romanò L, Fomiatti L, et al; SIMTI Research Group. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey. Transfusion 2008; 48: 2205-13.
38. Raimondo G, Allain JP, Brunetto MR, et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol 2008; 49: 652-7.